Black Diamond Therapeutics Inc at Piper Sandler Healthcare Conference Transcript
Okay, thank you. Just to remind, everybody this presentation contains forward-looking statements and data. So happy to be here to present the Black Diamond story. So Black Diamond is a unique precision medicine company. We're unique because we have developed MasterKey inhibitors that target families of oncogenic mutations.
And we do this with the intent of expanding the patient population that are treatable by a single therapy. Well, that will become evident as we go through the presentation today. We do this in a unique manner. We use population level DNA sequencing information from patients themselves.
We annotate those mutations. We've grouped them into families. And then we build small-molecule therapies that target the family of mutations, not individual mutations. And so in this way, we are able to expand the patient population that is treatable with a single therapy. We have two programs in clinical development. We'll come to that in just a moment.
But it's important to point out that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |